NEW YORK (GenomeWeb News) – Eurofins MWG Operon today announced it has acquired gene synthesis firm Entelechon for an undisclosed amount.

Entelechon was founded in 1999 in Regensburg, Germany, and focuses on genomics and proteomics projects "bringing broad experience in the fields of gene optimization and synthesis," Eurofins MWG Operon, the genomics division of Eurofins Scientific, said. The company serves the drug manufacturing industry as well as academic and public research institutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.